stockrowBioCryst Pharmaceuticals, Inc. (BCRX) vs Prestige Consumer Healthcare Inc. (PBH)
- BioCryst Pharmaceuticals, Inc. BCRX 7.67 +0.52%
- Prestige Consumer Healthcare Inc. PBH 42.93 −3.14%
BioCryst Pharmaceuticals, Inc. and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. BioCryst Pharmaceuticals, Inc. and Prestige Consumer Healthcare Inc. are of similar size ($2.1B and $2.0B). BioCryst Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.7×. BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 60.3% against 5.10%. Prestige Consumer Healthcare Inc. has the higher net margin (13.3% vs −37.4%) and the higher return on invested capital (9.59% vs 0.00%). Across the 18 metrics below, BioCryst Pharmaceuticals, Inc. leads on 10 and Prestige Consumer Healthcare Inc. on 8.
Valuation
Profitability
| Metric | BCRX | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.89% | 52.47% | 53.51% |
| Operating margin | (30.10%) | 24.95% | 0.00% |
| Net margin | (37.41%) | 13.29% | (2.45%) |
| Free cash flow margin | 38.11% | 18.35% | 0.00% |
| Return on equity | 91.60% | 8.23% | (0.80%) |
| Return on assets | (69.33%) | 3.80% | (1.67%) |
| Return on invested capital | 0.00% | 9.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack